Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Страна 1 од 121 резултати
Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
The endocannabinoid system is a possible target in the treatment of eating disorders. We used positron emission tomography to investigate the type 1 cannabinoid receptor (CB1R) in bulimic and anorectic patients.
METHODS
We investigated 16 female bulimia nervosa patients (BN) (age = 23.8 ±
[Cannabinoids in the treatment of the cachexia-anorexia syndrome in palliative care patients].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Loss of appetite and cachexia are frequent symptoms in palliative care patients. However, therapeutic regimens often prove ineffective, and the quality of life of many patients is significantly impaired by these symptoms. Causes and pathophysiology of anorexia and cachexia are complex and must be
Do cannabinoids constitute a therapeutic alternative for anorexia nervosa?
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
Cannabinoids have been postulated as an alternative for anorexia nervosa. However, their actual clinical efficacy and safety are still discussed.
METHODS
To answer this question we used Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening
Treatment studies with cannabinoids in anorexia nervosa: a systematic review.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with advanced cancer?
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
Cachexia and anorexia are among the most frequent symptoms in patients with cancer. Cannabinoids have been used in patients with advanced cancer; however, their role is still controversial.
METHODS
To answer this question we used Epistemonikos, the largest database of systematic reviews
Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Anorexia nervosa (AN) is a severe and disabling psychiatric disorder, characterized by profound weight loss and body image disturbance. Family and twin studies indicate a significant genetic contribution to this disorder although no genetic mutation has yet been identified. The endocannabinoid
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Anorexia can affect up to 90 % of people with advanced cancer. It is a complex symptom associated with changes in taste, lack of hunger at mealtimes and lack of food enjoyment. Associated weight loss is part of the physical decline that occurs as cancer worsens. Weight loss can also occur from
Cannabinoid CB1 /CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
Anorexia nervosa (AN) is a serious psychiatric condition characterized by excessive body weight loss and disturbed perceptions of body shape and size, often associated with excessive physical activity. There is currently no effective drug-related therapy of this disease and this leads to
The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Anorexia nervosa (AN) is characterized by anhedonia whereby patients experience little pleasure or reward in many aspects of their lives. Reward pathways and the endocannabionid system have been implicated in the mediation of food intake. The potential to exploit these systems to reverse weight loss
Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
The systemic and cognitive side effects of hepatitis C virus (HCV) therapy may be incapacitating, necessitating dose reductions or abandonment of therapy. Oral cannabinoid-containing medications (OCs) ameliorate chemotherapy-induced nausea and vomiting, as well as AIDS wasting syndrome.
The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Background: Cancer-related cachexia and anorexia syndrome (CACS) is a common phenomenon in cancer patients. Cannabis has been suggested to stimulate appetite but research on this issue has yielded mixed results. The current study aimed to evaluate the effect of dosage-controlled cannabis
Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To compare the effects of cannabis extract (CE), delta-9-tetrahydrocannabinol (THC), and placebo (PL) on appetite and quality of life (QOL) in patients with cancer-related anorexia-cachexia syndrome (CACS).
METHODS
Adult patients with advanced cancer, CACS, weight loss (> or = 5% over 6
Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
Several lines of evidence strongly implicate a dysfunctional endocannabinoid system (ECS) in eating disorders. Using [(18)F]MK-9470 and small animal positron emission tomography (PET), we investigated for the first time cerebral changes in type 1 cannabinoid (CB1) receptor binding in vivo
Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Is the clinical use of cannabis by oncology patients advisable?
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The use of the cannabis plant for various medical indications by cancer patients has been rising significantly in the past few years in several European countries, the US and Israel. The increase in use comes from public demand for the most part, and not due to a scientific basis. Cannabis chemistry
Најкомплетнија база лековитог биља подржана науком
- Ради на 55 језика
- Биљни лекови потпомогнути науком
- Препознавање биљака по слици
- Интерактивна ГПС мапа - означите биље на локацији (ускоро)
- Читајте научне публикације повезане са вашом претрагом
- Претражите лековито биље по њиховим ефектима
- Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима
Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима
